Delivery Order SPE2DB24D1104-SPE2DB25FYFS2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,413.30 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) on August 21, 2025, with an ultimate completion date of August 22, 2025. This contract represents a firm fixed price, non-set-aside delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Humalog 100 Unit/mL vials (10mL) with a ceiling value of $1,884.40. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $1 billion and extends through December...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,177.75 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/ML vials (10 ML) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,317.86 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This order is for 4,565,152,638 units of the drug Humalog (insulin lispro) in 10 mL vials, with a performance period through July 16, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Humalog 100 Unit/mL vials (10 mL) with a ceiling value of $1,472.06. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 9, 2025, issued on September 8, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $45,540 to Amerisourcebergen Drug Corporation under an indefinite-delivery/indefinite-quantity contract vehicle. The delivery order is for 4561772152 units of Humalog insulin vials, with each vial containing 100 units/mL and a volume of 10mL. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania over a period of one day, from August 10th to August 11th, 2023. The pricing structure is...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $455.40 to Amerisourcebergen Drug Corporation. The order is for 4562070776 units of Humalog 100 insulin vials with 10 milliliters per vial to support the Department of Defense. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from September 6 to September 7, 2023. The delivery order was issued under an existing DLA contract vehicle but no additional...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,267.94 to AmerisourceBergen Drug Corp for the supply of Humalog 100 Unit/mL vials (10mL) under a firm fixed price contract. This award, announced on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger indefinite delivery contract vehicle. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $1,253.30 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562194101 Humalog 100 unit/ml vials in quantities of 10ml each. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 15 through September 18, 2023. As the DLA supports the medical supply needs of the Department of Defense, this delivery order for insulin appears to be...
- The Defense Logistics Agency awarded a delivery order valued at approximately $546 to Amerisourcebergen Drug Corporation for the supply of 100 unit/ml vials of Humalog insulin. As the prime contractor, Amerisourcebergen will provide 10 ml vials of the drug to fulfill requirements under the delivery order. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of 3 days from August 11th through the 14th of 2023. The fixed-price contract was awarded...
- SPE2DB24D1104Indefinite Delivery Contract
- SPE2DB24D1104-SPE2DB25FYFS2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,130.64 to AmerisourceBergen Drug Corp for Humalog 100 Unit/ML vials (10 ml) on September 10, 2025, with completion scheduled for September 11, 2025. This competitive award with firm fixed pricing represents a small-value pharmaceutical procurement utilizing no set-aside designation. The contract is performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, and falls under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, fulfills essential pharmaceutical supply needs for military and veteran healthcare systems through the DLA Medical Supply Chain. This delivery order for insulin demonstrates the contractor's role in supporting Defense Health Agency operations and broader federal healthcare programs. The underlying IDC vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a diverse portfolio of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/10/25 |